# Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome

**Authors:** Keyvan Razazi, Enora Berti, Jerome Cecchini, Guillaume Carteaux, Anoosha Habibi, Pablo Bartolucci, Romain Arrestier, Ségolène Gendreau, Nicolas de Prost, Anne Hulin, Armand Mekontso Dessap

PMC · DOI: 10.1371/journal.pone.0319527 · 2025-02-12

## Full-text entities

- **Diseases:** sickle cell disease (MESH:D000755), acute chest syndrome (MESH:D056586)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11819519